037 – Sangamo Bounces Back! Viking’s Backup Drug

In this video, I go through Sangamo’s updated data with their Hemophilia A and Beta-Thalassemia treatments. I also talk about Viking Therapeutics’ VK5211, a potent selective androgen receptor modulator.

Follow me @matthewlepoire

*This is not investment advice*

http://www.breakingbiotech.com

#breakingbiotech #SGMO #VKTX

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s